In This Section      
 

Research Trials: Oncology

For more information, please contact Suburban Hospital Oncology Research:
Barbara Squiller: 301-896-2719
Melissa Hyman: 301-896-3221

TopicStudy NamePrincipal Investigator
BreastRandomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer, A011401, BWEL Study Learn MoreCarolyn B. Hendricks, M.D.
BreastStudy of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma, J1828 Learn MoreSusan Stinson, M.D.
BreastStudy Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy. A221405 POSITIVE  Learn MoreCarolyn B. Hendricks, M.D.
BreastA Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with Early Stage Breast Cancer J13104/PBI 3.0  Learn MoreSusan Stinson, M.D.
BreastAspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy, A011502 The ABC Trial  Learn MoreCarolyn B. Hendricks, M.D.
BreastProspective survey of oncoplastic reduction for breast cancer. SIB1567
Call 301-896-2719 or 301-896-3221
Bonnie Sun, M.D.
BreastOlaparib as Adjuvant Treatment in Patients with Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA). B55
Learn more
Carolyn B. Hendricks, M.D.
BreastA Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy. A011202 Learn morePamela Wright, M.D.
BreastA Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy . B-51 Learn moreSusan Stinson, M.D.
BreastPhase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. S1207 Learn MoreCarolyn B. Hendricks, M.D.
BreastMolecular Genetic Studies in Cancer. Call 301-896-2719 or 301-896-3221Carolyn B.Hendricks, M.D.
BrainA pilot study to assess safety and feasibility of 5 fraction hypofractionated stereotactic radiosurgery (treating tumor and edema) along with standard temozolomide for newly diagnosed glioblastoma, including assessment of lymphocyte sparing effect. J1745
Learn more
Brandi Page, M.D.
BrainSubventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme. J1426
Learn more
Brandi Page, M.D.
BrainLow Dose Radiation Therapy for Glioblastoma Multiforme. J11120
Learn more
Brandi Page, M.D.
ProstateHypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate. J0859 Learn moreStephen Greco, M.D.
ProstateSALV-ENZA: Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men with High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy. J1454 Learn moreStephen Greco, M.D.
LiverLiver Y-90 Humanitarian Use of Intra-arterial Y-90 TheraSpheres for Hepatocellular Carcinoma or Hepatic Metastases from Solid Tumorschange PI. Call 301-896-2719 or 301-896-3221.Andrew Ackman, M.D.
Indoor posed shot of the five-person Oncology Research Team Oncology Research Team